Growth Hormone Disorders Completed Phase 4 Trials for Somatotropin (DB00052)

Also known as: Growth Hormone Disorder

IndicationStatusPhase
DBCOND0036845 (Growth Hormone Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01562834Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult PatientsTreatment
NCT00567385Liquid Somatropin Formulation in Children With Growth Hormone DeficiencyTreatment